About GDNF family receptor alpha-1
GDNF family receptor alpha-1 (GFRA1) is a protein
from Homo sapiens identified by UniProt accession
P56159, 465 residues long.
MolForge cross-references it against 0 known binders and
196 disease associations.
Target properties
| Protein name | GDNF family receptor alpha-1 |
| UniProt accession | P56159 |
| Gene | GFRA1 |
| Organism | Homo sapiens |
| Length | 465 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (196)
Diseases linked to this target (Open Targets).
- blood protein measurement · score 0.38
- bilateral renal agenesis · score 0.37
- IGF-1 measurement · score 0.31
- insulin like growth factor measurement · score 0.31
- glioblastoma multiforme · score 0.30
- diet measurement · score 0.28
- appendicular lean mass · score 0.26
- renal agenesis · score 0.19
- neurodegenerative disease · score 0.19
- Hirschsprung disease · score 0.15
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-P56159-F1 | alphafold | PREDICTED | 74.11 | — |
Amino-acid sequence (465 residues)
MFLATLYFAL PLLDLLLSAE VSGGDRLDCV KASDQCLKEQ SCSTKYRTLR QCVAGKETNF SLASGLEAKD ECRSAMEALK QKSLYNCRCK RGMKKEKNCL RIYWSMYQSL QGNDLLEDSP YEPVNSRLSD IFRVVPFISD VFQQVEHIPK GNNCLDAAKA CNLDDICKKY RSAYITPCTT SVSNDVCNRR KCHKALRQFF DKVPAKHSYG MLFCSCRDIA CTERRRQTIV PVCSYEEREK PNCLNLQDSC KTNYICRSRL ADFFTNCQPE SRSVSSCLKE NYADCLLAYS GLIGTVMTPN YIDSSSLSVA PWCDCSNSGN DLEECLKFLN FFKDNTCLKN AIQAFGNGSD VTVWQPAFPV QTTTATTTTA LRVKNKPLGP AGSENEIPTH VLPPCANLQA QKLKSNVSGN THLCISNGNY EKEGLGASSH ITTKSMAAPP SCGLSPLLVL VVTALSTLLS LTETS
Explore GDNF family receptor alpha-1 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets